Testing a new kidney disease drug in patients with kidney failure
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests the safety of a new medicine (MK-2828) in people with advanced kidney disease or on dialysis, and compares them to healthy volunteers. The goal is to understand how the drug works in the body and if it's safe for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe kidney disease (eGFR less than 30) but are not on dialysis, OR you have end-stage kidney disease and have been on regular dialysis for at least 3 months.
- You are generally in good health aside from your kidney condition.
- You do not have other serious illnesses that could interfere with the study, like uncontrolled heart disease or diabetes.
- If you are healthy (without kidney disease), you must have no significant medical history such as stroke, seizures, or major organ problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
This study tests HRS-7535, a new oral tablet that may help protect kidneys in people with chronic kidney disease. GLP-1 medications were originally developed for diabetes but may also benefit kidney function and overall health.
This trial tests a new medication called MTX-439. It includes healthy adults and people with diabetic kidney disease to see if the drug is safe and to learn how the body handles it.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.